Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Audit Finding: Emergency Changes

GMP Gap: Temporary SOP Changes Not Documented

Posted on By

GMP Gap: Temporary SOP Changes Not Documented Failure to Document Temporary SOP Changes: A Critical GMP Compliance Breakdown Introduction to the Audit Finding 1. Nature of the Finding Temporary changes made to standard procedures were executed during manufacturing or quality operations but not documented formally through the change control system. 2. Why It’s a Compliance…

Read More “GMP Gap: Temporary SOP Changes Not Documented” »

Emergency Changes, GMP Audit Findings

Temporary SOP Changes Without Change Control: A Hidden Compliance Gap

Posted on By

Temporary SOP Changes Without Change Control: A Hidden Compliance Gap Unapproved Temporary SOP Changes: A Risky Shortcut in GMP Environments Introduction to the Audit Finding 1. Unrecorded Emergency Changes Violate GMP Temporary alterations to SOPs during emergencies must be documented under formal change control. Failure to do so constitutes a serious compliance gap. 2. Common…

Read More “Temporary SOP Changes Without Change Control: A Hidden Compliance Gap” »

Emergency Changes, GMP Audit Findings

Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events

Posted on By

Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events GMP Risks of Verbal Instructions Without SOP Addendum During Critical Events Introduction to the Audit Finding 1. Verbal Orders Bypass SOP Controls Issuing verbal instructions during critical operations without SOP addendums undermines written procedural control — a core GMP principle. 2. Common in Emergency or…

Read More “Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events” »

Emergency Changes, GMP Audit Findings

Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness

Posted on By

Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness Overlooking SOP Revisions After Emergency Measures: A GMP Oversight Introduction to the Audit Finding 1. Emergency Measures Should Not Be Permanent Emergency actions in GMP operations are intended to be short-term responses — not lasting procedures unless properly documented and approved. 2. Risk of…

Read More “Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness” »

Emergency Changes, GMP Audit Findings

Lack of Training Following Temporary SOP Adjustments: A Compliance Gap

Posted on By

Lack of Training Following Temporary SOP Adjustments: A Compliance Gap Training Deficiencies After Temporary SOP Adjustments: A Hidden GMP Risk Introduction to the Audit Finding 1. Untrained Staff Apply Uncontrolled Methods After a temporary change in SOP, if staff are not promptly trained, they continue using old or inconsistent methods — a GMP risk. 2….

Read More “Lack of Training Following Temporary SOP Adjustments: A Compliance Gap” »

Emergency Changes, GMP Audit Findings

Conflicting Procedures During Line Stoppage: A GMP Compliance Breakdown

Posted on By

Conflicting Procedures During Line Stoppage: A GMP Compliance Breakdown Resolving SOP Conflicts During Line Stoppages to Ensure GMP Compliance Introduction to the Audit Finding 1. Conflicting Instructions During Line Halt Line stoppages triggered by machine failure, contamination, or power issues often activate conflicting SOPs, leading to confusion among operators and supervisors. 2. Risk to Product…

Read More “Conflicting Procedures During Line Stoppage: A GMP Compliance Breakdown” »

Emergency Changes, GMP Audit Findings

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme